Catalent, Inc. (CTLT)
NYSE: CTLT · Real-Time Price · USD
59.68
+0.68 (1.15%)
Nov 21, 2024, 1:19 PM EST - Market open
Catalent Market Cap
Catalent has a market cap or net worth of $10.83 billion as of November 21, 2024. Its market cap has increased by 72.57% in one year.
Market Cap
10.83B
Enterprise Value
15.32B
1-Year Change
72.57%
Ranking
Category
Stock Price
$59.68
Market Cap Chart
Since July 31, 2014, Catalent's market cap has increased from $2.34B to $10.83B, an increase of 361.96%. That is a compound annual growth rate of 15.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 10.71B | 31.95% |
| Dec 29, 2023 | 8.12B | 0.20% |
| Dec 30, 2022 | 8.10B | -63.04% |
| Dec 31, 2021 | 21.92B | 27.87% |
| Dec 31, 2020 | 17.14B | 108.08% |
| Dec 31, 2019 | 8.24B | 81.73% |
| Dec 31, 2018 | 4.53B | -16.95% |
| Dec 29, 2017 | 5.46B | 62.28% |
| Dec 30, 2016 | 3.36B | 7.91% |
| Dec 31, 2015 | 3.12B | -9.71% |
| Dec 31, 2014 | 3.45B | 47.21% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Globus Medical | 11.38B |
| AptarGroup | 11.23B |
| Bio-Techne | 10.92B |
| Smith & Nephew | 10.74B |
| Vaxcyte | 10.71B |
| Sarepta Therapeutics | 10.59B |
| Medpace Holdings | 10.11B |
| Encompass Health | 9.97B |